Weifang Medical University, Weifang 261053, China; Jinan Central Hospital, Jinan 250013, China.
Department of Radiology, Central Hospital Affiliated to Shandong First Medical University, Jinan 250013, China; Department of Radiology, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250013, China.
Clin Radiol. 2022 Sep;77(9):e705-e710. doi: 10.1016/j.crad.2022.05.029. Epub 2022 Jun 29.
To evaluate the feasibility of an ultra-low volume contrast media (CM) protocol for coronary computed tomography angiography (CTA).
In total, 214 patients receiving coronary CTA were enrolled prospectively and divided into group A (n=107) receiving a conventional dose of CM and group B (n=107) receiving an ultra-low dose. CT values of the right coronary artery (RCA), left anterior descending artery (LAD), and left circumflex artery (LCX) were measured and radiation doses recorded. The image quality was compared between the groups. Changes in renal function indices and proteinuria before, 24, and 72 hours after coronary CTA among those with chronic kidney disease (CKD) were also assessed.
There were significant differences in CT values and radiation doses between groups A and B. In group A, the average RCA, LAD, and LCX CT values were 412.5 ± 79.2, 423.5 ± 73.7, and 422.0 ± 88.1 HU, respectively. In group B, the average RCA, LAD, and LCX CT values were 275.2 ± 16.2, 277.8 ± 16.4, and 278.9 ± 16.5 HU, respectively. The radiation dose in the ultra-low protocol recipients (118.70 ± 18.52 mGy·cm) was significantly lower than that used in conventional coronary CTA (131.75 ± 20.96 mGy·cm). The image quality of group B was comparable to that of group A, satisfying the diagnostic requirement. In patients with mild CKD, there were no significant differences in renal functions after coronary CTA.
An ultra-low CM protocol was established for coronary CTA, providing comparable image quality and diagnostic yields but significantly lower radiation dose compared with a conventional protocol. This new protocol might be applicable to patients with mild CKD.
评估冠状动脉计算机断层血管造影术(CTA)中超低量造影剂(CM)方案的可行性。
前瞻性纳入 214 例行冠状动脉 CTA 的患者,分为 A 组(n=107)给予常规剂量 CM 和 B 组(n=107)给予超低剂量。测量右冠状动脉(RCA)、左前降支(LAD)和左旋支(LCX)的 CT 值并记录辐射剂量。比较两组间的图像质量。还评估了慢性肾脏病(CKD)患者冠状动脉 CTA 前后 24 小时和 72 小时肾功能指标和蛋白尿的变化。
A 组和 B 组的 CT 值和辐射剂量存在显著差异。A 组 RCA、LAD 和 LCX 的平均 CT 值分别为 412.5±79.2、423.5±73.7 和 422.0±88.1 HU。B 组 RCA、LAD 和 LCX 的平均 CT 值分别为 275.2±16.2、277.8±16.4 和 278.9±16.5 HU。超低方案受检者的辐射剂量(118.70±18.52 mGy·cm)明显低于常规冠状动脉 CTA(131.75±20.96 mGy·cm)。B 组的图像质量与 A 组相当,满足诊断要求。在轻度 CKD 患者中,冠状动脉 CTA 后肾功能无显著差异。
为冠状动脉 CTA 建立了超低 CM 方案,与常规方案相比,提供了可比的图像质量和诊断效果,但辐射剂量明显降低。该新方案可能适用于轻度 CKD 患者。